A Q&A with Robin Feldman

Last month, four academics published a joint paper criticising the increasing levels of concentration in the pharmaceutical sector and raising concerns about how widespread industry practices like common ownership could impede proper merger reviews. GCR USA spoke with UC Hastings College of Law professor Robin Feldman, one of the study’s authors, about the implications of those findings.

Unlock unlimited access to all Global Competition Review content